Brain metastases (BMs) are a devastating complication of cancer, occurring ten times more frequently than primary brain ...

Brain metastases are one of the most severe complications of melanoma, the most aggressive type of skin cancer. Researchers ...

Using an intracardiac melanoma metastasis mouse model and RNA sequencing, the team identified significant alterations in gene expression, particularly in ferroptosis-related pathways. A key ...

Using an intracardiac melanoma metastasis mouse model and RNA sequencing, the team identified significant alterations in gene expression, particularly in ferroptosis-related pathways. A key ...

Opinions expressed by Forbes Contributors are their own. Dario Sabaghi covers the cannabis industry with a focus on Europe. A recent in-vitro study reveals that a cannabis extract can potentially ...

This pathway activation enhances the therapeutic ... In phase 1, MDX-1106 treatment led to 15 confirmed responses among 46 metastatic melanoma patients. As of June, none of the responders had ...

Erasca is a biotech company focused on developing therapies for RAS/MAPK pathway-driven cancers with a strong financial ...

Until recently, uveal melanoma was a disease that was poorly ... the side effects from previous drugs that work along this pathway, such as hyperglycemia, dermatitis and rash, stomatitis ...

Naporafenib is Erasca’s main candidate, and it has Fast Track status for NRASm melanoma. See why I rate ERAS stock as a buy.